News

London-A reduction in IOP in patients with open-angle glaucoma can be achieved after nonpenetrating glaucoma surgery (canaloplasty) when circumferential suturing is done in the inner wall of Schlemm's canal. This technique results in distension of Schlemm's canal and enhanced outflow of aqueous with the subsequent lowering of the IOP, explained Norbert Koerber, MD, at the XXIV Congress of the European Society of Cataract and Refractive Surgeons in London.

Irvine, CA-Ophthalmic device manufacturer Refractec Inc. announced the appointment of Richard L. Lindstrom, MD, of Minnesota Eye Consultants, to its six-member board of directors.

Boston-The Massachusetts Eye and Ear Infirmary (MEEI) appointed Reza Dana, MD, MSc, MPH, of Cambridge, MA, as director of its cornea and refractive surgery service. Dr. Dana has been an associate surgeon at MEEI since 2001 and has served as acting director of the cornea and refractive surgery service since April.

Hinsdale, IL-Preoperative topical application of semi-frozen balanced salt solution (BSS) given immediately before the epi-keratome pass is a highly effective technique for significantly reducing or even eliminating pain after epi-LASIK, said Bruce Larson, MD, who is a clinical instructor, Loyola University Medical Center, Maywood, IL, and in private practice in Hinsdale, IL.

Many factors play a role in wound healing after epi-LASIK. For example, use of nonsteroidal anti-inflammatory drugs (NSAIDs) after surgery, advanced age, and a compromised tear film have been associated with delayed wound healing, whereas younger age, healthy tear film, and certain nutritional supplements have been associated with rapid wound healing.

Triamcinolone acetonide injections for macular edema associated with retinal vein occlusion have become a therapeutic mainstay, but conflicting data have emerged about the safety of these injections, and some reports indicate that visual stabilization rather than visual improvement is occurring.

A study on the natural course of primary acquired melanosis of the conjunctiva (PAM) shows that there is no risk of progression to melanoma if there is no atypia, with increasing risk for mild to severe atypia.

Triamcinolone acetonide injections for macular edema associated with retinal vein occlusion have become a therapeutic mainstay, but conflicting data have emerged about the safety of these injections, and some reports indicate that visual stabilization rather than visual improvement is occurring.

"The best way to improve your bottom line is to improve your top lines-sell luxury, branded eyewear," said Sam Buemi, regional manager, Safilo USA. "If you carry fashion eyewear and your staff learns to sell fashion eyewear, your bottom line will improve."

In a retrospective analysis of the phase III MARINA study results, patients with neovascular age-related macular degeneration (AMD) who were treated with the 0.5-mg dose of ranibizumab (Lucentis, Genentech) had improvement in anatomic outcomes that corresponded to improved visual acuity and was compared to a sham group, according to Nancy M. Holekamp, MD.

Oral antiviral medications offer an effective, more convenient option compared with topical antiviral therapy for patients with acute infectious ulcers associated with herpes simplex keratitis, increasing the likelihood of therapy adherence, Deborah P. Langston, MD, FACS, told a full-capacity crowd at a symposium on eye infections Monday

The Foresee PHP, a second-generation Preferential Hyperacuity Perimeter is available for improved detection and early diagnosis of the most aggressive and sight-threatening form of age-related macular degeneration (AMD). Developed by Notal Vision and distributed exclusively in the United States by MSS, the device represents a technologic leap for monitoring AMD and is a clinically validated diagnostic device for improved early detection of choroidal neovascularization (CNV).

Neuroprotection, a strategy to slow or prevent the death of retinal ganglion cells, offers the possibility of slowing the rate of glaucomatous progression and preventing blindness. But although the underlying theory appears to be sound, much has yet to be learned through basic and clinical research before neuroprotection could become an integral part of glaucoma therapy.

There are a number of measures that can be employed to improve success with implantation of the new IOLs. Speaking in a spotlight session on pseudophakic IOLs at the annual meeting of the American Academy of Ophthalmology, Samuel Masket, MD, presented a series of clinical tips for achieving excellent results and high patient satisfaction in recipients of the AcrySof ReSTOR (Alcon Laboratories) apodized diffractive IOL.

Blue-light-filtering IOLs provide protection against potential blue light toxicity without significantly affecting clinical functioning of recipients, said James D. McCulley, MD, during a spotlight session on pseudophakic IOLs at the annual meeting of the American Academy of Ophthalmology.

The Anecortave Acetate Risk Reduction Trial has met its patient enrollment requirement with almost 2,600 individuals who are at high risk for developing choroidal neovascularization (CNV) or advanced age-related macular degeneration (AMD) over time, reported Jason Slakter, MD, at a retina free papers session during the American Academy of Ophthalmology annual meeting.

Conductive keratoplasty corrects mild-to-moderate hyperopia, but the results may not be permanent, reported Jason Erlich, MD. He and colleagues conducted a study to determine the long-term results of conductive keratoplasty for the treatment of hyperopia.